 Braxia Scientific Corp announced that it has completed psilocybin-assisted therapy training of the first cohort of 20 therapists from diverse psychiatry and psychotherapy backgrounds. This program was implemented by the Braxia Institute, the companys training center focused on advancing psychiatric clinical practice and health services of ketamine and psychedelic treatment therapy. 